Aclidinium Bromide Powder for Inhalation(Joincare Pharmaceutical Group)

阿地溴铵吸入粉雾剂(健康元药业集团)

Report date: 2025/09/08 16:35:30

Base Information

Drug NameAclidinium Bromide Powder for Inhalation(Joincare Pharmaceutical Group)
Drug Alias Namebromuro de aclidinio阿利溴铵bromure d’aclidinium阿地溴铵吸入粉雾剂(2.2类改良型)aclidinii bromidum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A